News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
27,613 Results
Type
Article (1173)
Press Release (26440)
Section
Business (13755)
Career Advice (55)
Deals (1651)
Drug Development (1865)
FDA (386)
Job Trends (486)
News (16841)
Policy (637)
Tag
Academia (31)
Accelerated approval (2)
Allergies (2)
Alliances (815)
ALS (3)
Alzheimer's disease (35)
Antibody-drug conjugate (ADC) (11)
Approvals (406)
Artificial intelligence (4)
Autoimmune disease (5)
Bankruptcy (10)
Best Places to Work (427)
Biosimilars (2)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (23)
Cancer (140)
Cardiovascular disease (12)
Career advice (39)
CAR-T (1)
Cell therapy (16)
Cervical cancer (1)
Clinical research (1701)
Collaboration (25)
Compensation (23)
COVID-19 (30)
CRISPR (1)
C-suite (5)
Cystic fibrosis (3)
Data (206)
Depression (5)
Diabetes (18)
Diagnostics (268)
Digital health (2)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (13792)
Events (2188)
Executive appointments (1)
FDA (578)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (13)
Gene editing (3)
Generative AI (1)
Gene therapy (5)
GLP-1 (38)
Government (58)
Guidances (144)
Healthcare (698)
HIV (4)
IgA nephropathy (4)
Immunology and inflammation (5)
Immuno-oncology (5)
Indications (3)
Infectious disease (37)
Inflammatory bowel disease (4)
Influenza (4)
Intellectual property (2)
Interviews (3)
IPO (1296)
Job creations (89)
Job search strategy (38)
JPM (1)
Layoffs (8)
Legal (159)
Liver cancer (3)
Lung cancer (31)
Lymphoma (14)
Manufacturing (6)
MASH (10)
Medical device (635)
Medtech (639)
Mergers & acquisitions (358)
Metabolic disorders (48)
Multiple sclerosis (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (5)
Neuroscience (59)
NextGen: Class of 2026 (108)
Non-profit (34)
Obesity (23)
Opinion (2)
Ovarian cancer (7)
Pain (1)
Pancreatic cancer (3)
Parkinson's disease (2)
Patents (2)
Patient recruitment (5)
Peanut (2)
People (566)
Pharmacy benefit managers (1)
Phase 1 (408)
Phase 2 (666)
Phase 3 (694)
Pipeline (587)
Postmarket research (90)
Preclinical (199)
Press Release (2)
Prostate cancer (4)
Radiopharmaceuticals (17)
Rare diseases (14)
Real estate (84)
Regulatory (492)
Reports (4)
Research institute (20)
Resumes & cover letters (14)
RSV (4)
Schizophrenia (3)
Series A (2)
Series B (3)
Sickle cell disease (2)
Spinal muscular atrophy (6)
Sponsored (3)
Startups (42)
Supply chain (1)
Vaccines (6)
Venture capital (1)
Weight loss (21)
Women's health (3)
Date
Today (18)
Last 7 days (32)
Last 30 days (70)
Last 365 days (1572)
2026 (88)
2025 (1581)
2024 (1786)
2023 (2032)
2022 (3869)
2021 (2778)
2020 (2008)
2019 (1087)
2018 (901)
2017 (647)
2016 (368)
2015 (541)
2014 (469)
2013 (216)
2012 (6470)
2011 (409)
2010 (387)
Location
Africa (20)
Alabama (2)
Arizona (6)
Asia (1718)
Australia (162)
California (532)
Canada (143)
China (25)
Colorado (26)
Connecticut (27)
Delaware (35)
Europe (3481)
Florida (99)
Georgia (34)
Illinois (33)
India (1)
Indiana (42)
Japan (29)
Kansas (2)
Kentucky (4)
Louisiana (5)
Maine (10)
Maryland (69)
Massachusetts (413)
Michigan (19)
Minnesota (37)
Missouri (6)
Nevada (6)
New Hampshire (5)
New Jersey (174)
New York (167)
North Carolina (102)
Northern California (310)
Ohio (9)
Pennsylvania (117)
South America (39)
Southern California (188)
Tennessee (7)
Texas (59)
United States (2090)
Utah (25)
Virginia (5)
Washington D.C. (2)
Washington State (41)
Wisconsin (4)
27,613 Results for "137".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
December 23, 2025
·
5 min read
Press Releases
AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
December 15, 2025
·
5 min read
Press Releases
AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
November 10, 2025
·
3 min read
Press Releases
AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B
September 19, 2025
·
3 min read
Press Releases
Positive Study Results with TrkA-NAM ACD137 Against Knee Osteoarthritis Presented at Pain Conference NeuPSIG 2025
September 8, 2025
·
5 min read
Press Releases
New Scientific Data with TrkA-NAM ACD137 Against Knee Osteoarthritis to be Presented at Pain Conference
August 5, 2025
·
5 min read
Press Releases
AusperBio Receives China CDE Clearance to Advance AHB-137 into Phase III Clinical Trial for Chronic Hepatitis B
July 22, 2025
·
3 min read
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move.
October 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
AusperBio Presents Interim Phase IIb AHB-137 Clinical Data in a Late-Breaking Abstract at EASL™ Congress 2025
May 8, 2025
·
3 min read
Biotech Bay
AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio) today announced the clinical data of the Company’s HBV ASO molecule, AHB-137, will be presented in two late-breaking posters, LBP-019 and LBP-043, at the annual European Association for the Study of the Liver (EASL™) Congress 2024, to be held in Milan, Italy, from June 5th to 8th, 2024.
May 28, 2024
·
3 min read
1 of 2,762
Next
